CONSIDERING QUESTION OF SAFETY OF DIRECT ORAL ANTICOAGULANTS: THE RESULTS OF THE COMPARISON OF APIXABAN AND WARFARIN

Abstract

The review analyzes data on the safety of apixaban for the prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation and venous thromboembolic complications obtained in randomized controlled studies.

Keywords

• atrial fibrillation
• deep vein thrombosis
• pulmonary artery thromboembolism
• bleeding
• apixaban
• warfarin